GLG News Analyses of the following article:

Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen

view article

Published at: www.pipelinereview.com

A good deal

January 14, 2008

GLG Expert Contributor

At present despite the statins we have, many do not reach goal. In fact. it may be that that goal is not adequate as we have still a major issue with cardiovascular disease. This product may prove to be a further advance along this line.

Subscribe to Updates

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines

Work for one of the world's leading organizations? Get started now.

Get Intelligently Connected
with the world's leading experts

GLG's 850+ Clients Include:

More than 70% of the world's leading
mutual funds
15 of the leading 20
global banks
9 of the leading 10
global private equity firms
5 of the leading 10
AmLaw firms
Fortune 500® Companies
in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software